Four international doctors will co-chair IASLC’s 2025 World Conference on Lung Cancer, which will take place September 6-9, 2025, in Barcelona. Get to know the incoming co-chairs who will help plan WCLC 2025 and serve as ambassadors for international attendees.
Isabelle Opitz, MD, is an Associate Professor and Director of the Department of Thoracic Surgery at University Hospital Zurich, Zurich, Switzerland. Dr. Opitz also serves as Chair of the Lung Cancer Center at the University Hospital Zurich. She has been an IASLC member since 2012 and has been involved in the IASLC Mesothelioma Taskforce, the N-Stage Committee for non-small cell lung cancer, and the malignant pleural mesothelioma Staging Subcommittee.
Umberto Malapelle is Associate Professor and Chair of the Predictive Molecular Pathology Laboratory for the Department of Public Health at the University of Naples Federico II in Naples, Italy. Prof. Malapelle served on the Liquid Biopsy Track for WCLC 2021 and the Program Committee for Tumor Biology & Biomarkers during WCLC 2022. He also presented during a 2023 WCLC Hot Topics on Lung Cancer Biomarkers education session.
Noemi Reguart, MD, PhD, is a medical oncologist and leads the Thoracic Oncology Unit at the Hospital Clinic Barcelona, Barcelona. Dr. Reguart has participated in numerous scientific committees and has been asked to speak at several WCLC and ACLC conferences. She has also been involved with the IASLC Communications Committee since 2020.
Jarushka Naidoo, MB, BCH, MHS, is Professor of Medical Oncology and Consultant Medical Oncologist at Beaumont RCSI Cancer Center, Dublin, Ireland, as well as an Adjunct Professor at Johns Hopkins University, Baltimore, Maryland. Dr. Naidoo serves as the Chair of the IASLC Communications Committee and was track chair of the Metastatic Immunotherapy track for WCLC 2024.
Dr. Naidoo is the founder and Chair of the Irish Lung Cancer Alliance research group and Chair of the Lung Cancer Disease-specific subgroup (DSSG) of Cancer Trials Ireland. She was named the Irish Cancer Society’s Clinician Research Leader from 2022 to 2024 and won the IASLC/LCFA Young Investigator Award in 2020.
